YOUR BUSINESS AUTHORITY
Springfield, MO
Danish drugmaker Novo Nordisk's parent company, Novo Holdings, has signed on for a $16.5 billion acquisition.
The company is buying drug manufacturer Catalent.
CNBC reports the deal could help shore up the supply of weight loss injection Wegovy and diabetes shot Ozempic.
Read more from CNBC.
Organizers hope to bolster client traffic to center city businesses.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
State awards Springfield $4.6M for wastewater system improvements
Stockton district names next superintendent
Trump, fast-food companies among targets of X redirects
Council modifies data center definitions bill, extends moratorium into next year